H&T Presspart will be in attendance at this year’s Respiratory Drug Delivery (RDD®) USA conference which will be held at the Omni Orlando Champions Gate, Orlando, Florida, from May 1st -5th, 2022.

During the conference which is being held face to face for the first time since the pandemic began, H&T Presspart’s Jacqueline Green will be hosting  a presentation of a poster entitled “Plasma Technology: An Innovative And Sustainable pMDI Surface Treatment”.

Throughout the presentation, Jacqueline will deliver information on the manufacturing process for H&T Presspart’s pMDI plasma cans and how the surface treatment combats drug degradation and drug adhesion internally, two common problems with MDIs.

The poster will also discuss the sustainability benefits of the plasma manufacturing process over other coated can processes such as anodised and FEP coated cans. Participants will also see how H&T Presspart’s inspection and quality process ensures the whole of the internal surface of the can is treated with plasma.

If you would like to arrange a meeting with Jacqueline or any other member of our team during RDD then please contact us.